Coverage
-
May 24, 2021
MiMedx Group Inc. can't get $40 million in restitution from two former executives who were convicted of a scheme to dupe the company's investors, a New York federal judge ruled Sunday, finding that the biologics company isn't a victim under the statute in question.
10 other articles on this case.
View all »